Clinical Trials Logo

High Viral Load clinical trials

View clinical trials related to High Viral Load.

Filter by:
  • None
  • Page 1

NCT ID: NCT04135235 Recruiting - Clinical trials for Chronic Hepatitis B Infection

Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B

Start date: August 1, 2019
Phase:
Study type: Observational

This study is a prospective study. The subject will select 440 cases of pregnant women with high hepatitis B virus load, and one group will take maternal and child blockade treatment with propofol fumarate. One group will take tenofovir disoproxil fumarate. Broken treatment, compare the failure rate of maternal and child blockade and the incidence of maternal and child adverse events in the two groups, and explore the efficacy and safety of propofol flavuril for the treatment of hepatitis B mother-infant block.

NCT ID: NCT01337791 Completed - Chronic Hepatitis B Clinical Trials

Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels

Start date: August 2008
Phase: Phase 4
Study type: Interventional

Telbivudine reduces DNA and normalizes alanine aminotransferase levels (ALT) in chronic hepatitis B patients with few adverse effects, but its use during pregnancy has not been explored. In this open-label, prospective study from the second trimester to post-partum week 28. This trial is to study the efficacy, safety and tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women with high level of serum HBV DNA and elevated alanine aminotransferase levels.